Arcus biosciences to participate in multiple upcoming investor conferences

Hayward, calif.--(business wire)--arcus biosciences (nyse:rcus), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, announced that its management team will participate in the following upcoming investor conferences in september: 2023 wells fargo healthcare conference date: wednesday, september 6th, 2023 at 10:15 a.m. et location: boston, ma format: fireside chat citi 18th annual biopharma conference.
RCUS Ratings Summary
RCUS Quant Ranking